IBD Serology and Disease Outcomes in African Americans With Crohn’s Disease
Author(s) -
Madeline Bertha,
Arthi Vasantharoopan,
Archana Kumar,
Bonnie Bruce,
Jarod Prince,
Tatyana Hofmekler,
David T. Okou,
Pankaj Chopra,
Gabriel Wang,
Cary G. Sauer,
Carol J. Landers,
Sunny Z. Hussain,
Raymond K. Cross,
Robert N. Baldassano,
Michael D. Kappelman,
Jeffrey A. Katz,
J. Steven Alexander,
Barbara S. Kirschner,
Dedrick E. Moulton,
B. O. Osuntokun,
Ashish Patel,
Shehzad A. Saeed,
JanMichael A. Klapproth,
Tanvi Dhere,
Marla C. Dubinsky,
Dermot McGovern,
Subra Kugathasan
Publication year - 2017
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izx021
Subject(s) - serology , disease , crohn's disease , odds ratio , medicine , inflammatory bowel disease , genotyping , immunology , logistic regression , gastroenterology , antibody , genotype , biology , genetics , gene
Recent studies have identified the role of serologic markers in characterizing disease phenotype, location, complications, and severity among Northern Europeans (NE) with Crohn's disease (CD). However, very little is known about the role of serology in CD among African Americans (AA). Our study explored the relationship between serology and disease phenotype in AA with CD, while controlling for genetic ancestry.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom